Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 334

The DOI matches its Crossref record; 141 of the 141 references it cites were found in a registry or an index.

New insights into pancreatic cancer-induced paraneoplastic diabetes

Open access
Sah, Raghuwansh P., Nagpal, Sajan Jiv Singh, Mukhopadhyay, Debabrata, Chari, Suresh T.·2013·Nature Reviews Gastroenterology & Hepatology

Abstract

Up to 85% of patients with pancreatic cancer have diabetes or hyperglycaemia, which frequently manifests as early as 2–3 years before a diagnosis of pancreatic cancer. Conversely, patients with new-onset diabetes have a 5–8-fold increased risk of being diagnosed with pancreatic cancer within 1–3 years of developing diabetes. Emerging evidence now indicates that pancreatic cancer causes diabetes. As in type 2 diabetes, β-cell dysfunction and peripheral insulin resistance are seen in pancreatic cancer-induced diabetes. However, unlike in patients with type 2 diabetes, glucose control worsens in patients with pancreatic cancer in the face of ongoing, often profound, weight loss. Diabetes and weight loss, which precede cachexia onset by several months, are paraneoplastic phenomena induced by pancreatic cancer. Although the pathogenesis of these pancreatic cancer-induced metabolic alterations is only beginning to be understood, these are likely mechanisms to promote the survival and growth of pancreatic cancer in a hostile and highly desmoplastic microenvironment. Interestingly, these metabolic changes could enable early diagnosis of pancreatic cancer, if they can be distinguished from the ones that occur in patients with type 2 diabetes. One such possible biomarker is adrenomedullin, which is a potential mediator of β-cell dysfunction in pancreatic cancer-induced diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nrgastro.2013.49

Cites

141 of 141 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 141 references

Research works printed but not linked: 12

  1. De Nunzio, C. & Tubaro, A. Prostate cancer: diabetes and prostate cancer—an open debate. Nat. Rev. Urol. 10, 12–14 (2012). · doi:10.1038/nrurol.2012.239
  2. Saruc, M. & Pour, P. M. Diabetes and its relationship to pancreatic carcinoma. Pancreas 26, 381–387 (2003). · doi:10.1097/00006676-200305000-00012
  3. Kim, T. D. et al. Clinical characteristics of pancreatic cancer according to the presence of diabetes mellitus [Korean]. Korean J. Gastroenterol. 43, 35–40 (2004).
  4. Permert, J. et al. Pancreatic cancer is associated with impaired glucose metabolism. Eur. J. Surg. 159, 101–107 (1993).
  5. Rosa, J. A., Van Linda, B. M. & Abourizk, N. N. New-onset diabetes mellitus as a harbinger of pancreatic carcinoma. A case report and literature review. J. Clin. Gastroenterol. 11, 211–215 (1989). · doi:10.1097/00004836-198904000-00020
  6. Silverstein, M. D., Richter, J. M., Podolsky, D. K. & Warshaw, A. L. Suspected pancreatic cancer presenting as pain or weight loss: analysis of diagnostic strategies. World J. Surg. 8, 839–845 (1984). · doi:10.1007/bf01656023
  7. Permert, J. et al. Islet amyloid polypeptide in patients with pancreatic cancer and diabetes. N. Engl. J. Med. 330, 313–318 (1994). · DOI · Paper page
  8. Wang, F., Adrian, T. E., Westermark, G., Gasslander, T. & Permert, J. Dissociated insulin and islet amyloid polypeptide secretion from isolated rat pancreatic islets cocultured with human pancreatic adenocarcinoma cells. Pancreas 18, 403–409 (1999). · doi:10.1097/00006676-199905000-00012
  9. Tisdale, M. J. Zinc- α-2-glycoprotein in cachexia and obesity. Curr. Opin. Support Palliat. Care 3, 288–293 (2009). · doi:10.1097/spc.0b013e328331c897
  10. Jiao, L. et al. Evidence that serum levels of the soluble receptor for advanced glycation end products are inversely associated with pancreatic cancer risk: a prospective study. Cancer Res. 71, 3582–3589 (2011). · DOI
  11. Permert, J., Herrington, M., Kazakoff, K., Pour, P. M. & Adrian, T. E. Early changes in islet hormone secretion in the hamster pancreatic cancer model. Teratog. Carcinog. Mutagen. 21, 59–67 (2001). · doi:10.1002/1520-6866(2001)21:1<59::aid-tcm6>3.0.co;2-v
  12. Pour, P. M. & Bell, R. H. Alteration of pancreatic endocrine cell patterns and their secretion during pancreatic carcinogenesis in the hamster model. Cancer Res. 49, 6396–6400 (1989).

Cited by

See all 334

Metadata

Authors
Sah, R. P., Nagpal, S. J. S., Mukhopadhyay, D., & Chari, S. T.
Venue
Nature Reviews Gastroenterology & Hepatology
Published
2013-03-26
Volume
10
Issue
7
Pages
423-433
ISSN
  • 1759-5045 (ISSN-L)
  • 1759-5053
OpenAlex
W2033654850
Cited by
334
References
141
FWCI
2.24
Type
journal article
Language
en
Open access
green
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: New insights into pancreatic cancer-induced paraneoplastic diabetes. https://app.cochat.ai/papers/10.1038/nrgastro.2013.49
The paper
Sah, R. P., Nagpal, S. J. S., Mukhopadhyay, D., & Chari, S. T. (2013). New insights into pancreatic cancer-induced paraneoplastic diabetes. Nature Reviews Gastroenterology & Hepatology. https://doi.org/10.1038/nrgastro.2013.49

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.